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Abstract
Background:  In order to assess the usefulness of radiolabeled white cell scanning in the diagnosis
of intestinal inflammation, subjects were asked to rank several dimensions of preference for white
cell scanning in relation to other diagnostic tests. Two groups were surveyed: one known to have
inflammatory bowel disease and the second not familiar in most cases with the tests. Subjects were
asked to rank preference for each of seven tests: radiolabeled white cell scan, colonoscopy, barium
enema, sigmoidoscopy, enteroclysis, stool analysis and laparotomy for the diagnosis of IBD and
impressions of discomfort, embarrassment, inconvenience and danger related to each test. Mean
rank scores were calculated, test ranks compared within groups and significance determined by the
Wilcoxon rank test.
Results:  Significant differences were seen in overall preference for white cell scan over barium
enema and colonoscopy (p < 0.01) in both survey groups. Perceived discomfort and
embarrassment demonstrated similar rankings.
Conclusion:  This patient preference combined with the reported accuracy of white cell scanning
further establishes the usefulness of this means of IBD diagnosis.
Background
The radio labeled white cell scan has been shown to be an
accurate means of detecting intestinal inflammation [1].
Our initial report of the use of Indium111 radiolabeled
white cell scanning in the diagnosis of inflammatory
bowel disease described a sensitivity and specificity of
97% and 100% respectively in 49 scans in 39 patients in
all of whom confirmatory studies were done. Since that
time, 1130 scans have been performed at our institution.
Clinical follow-up of these patients has revealed only
three cases of confirmed false negative scans. No cases of
false positive scans have been encountered. This accura-
cy, it should be stressed, is not in the grading of disease
activity, but in the dichotomous determination of disease
presence and its anatomic location. The lack of confirm-
atory testing of all subsequent patients certainly results
in the overestimation of accuracy [2], but not greatly so,
since all patients have been available for clinical follow-
up and diagnostic errors would become apparent with
the passage of time. Even if it is a ten fold overestimate,
the white cell scan still compares well with other diag-
nostic modalities. In 1993 Indium111 became unavailable
in Chicago and we switched to the use of Technetium99.
We found that the higher radiation dose of Technetium
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injected (20 mCI versus 0.5 mCI Indium) resulted in
clearer images with less motion artifact, yet its shorter
half life resulted in the total radiation dose to the patient
being similar to Indium111. First images are available
within 5 hours from the patient's arrival using Techne-
tium, compared with 30 hours for Indium, making this
applicable to emergent situations. In routine clinical fol-
low-up, no measurable change was noted in the number
of false positive or negative scans since the change to
Technetium99 (unpublished data). These advantages of
Technetium over Indium have resulted in our continued
use of Technetium for white cell scanning (WCS).
The further establishment of the usefulness of this diag-
nostic clinical intervention was our next goal. Usefulness
depends in the final analysis upon the likelihood that a
patient will decide to undergo the intervention. Patient
preference may therefore be an important part of the
process of determining clinical usefulness. In order to es-
tablish further its usefulness, a survey was conducted in
which subjects were asked to rank their preference for
white cell scanning in relation to other means of diagnos-
ing intestinal inflammation.
Methods
Questionnaire
The questionnaire designed for the study is presented in
the Appendix. It begins with a description of seven diag-
nostic tests of intestinal inflammation. These are colon-
oscopy, barium enema, radio-labeled white cell
scanning, flexible sigmoidoscopy, enteroclysis, explora-
tory surgery, and stool collection and analysis. Tests are
described both in terms of the preparation required for
the test and the test procedure itself.
Participants were then asked to rank order the seven
tests by overall preference, by perceived or anticipated
physical discomfort, by inconvenience, by embarrass-
ment, and by danger. Finally, they were asked to indicate
which of the tests, if any, they had previously experi-
enced, and their age and gender.
Participants and sampling
Two groups of participants were invited to respond to the
questionnaire: an experienced group and a naive group:
The experienced group were 25 patients of the University
of Illinois colorectal surgery clinic known to have inflam-
matory bowel disease (IBD), either ulcerative colitis or
Crohn's disease, and likely to have experienced most, if
not all, of the procedures described in the questionnaire.
Eighty-five such patients were mailed questionnaires
(response rate 30% - a low rate, typical of mailed ques-
tionnaires). Respondents ranged from 14-66 years old
with a median age of 38. Fifteen (60%) were women.
The naive group of participants were a convenience sam-
ple of 39 adults, consisting of parents or grandparents of
children visiting a general pediatrician's office and per-
sonnel working in that office. These participants had ex-
perienced few or none of the diagnostic tests.
93% of those requested by office staff to participate re-
turned the questionnaire. One participant failed to com-
plete the majority of the questionnaire and was dropped
from the study. Remaining participants ranged from 18-
81 years old with a median age of 44. Twenty six (68%)
were women.
Analyses
Data were analyzed using SPSS 9.0. Analyses reported
here focus on comparisons within the two groups only
and not across groups, between ranks assigned white cell
scanning, barium enema, and colonoscopy on preference
and the other assessed attributes. We also consider
whether these rank orders may differ between partici-
pants who have and have not received these tests. The
other tests in the questionnaire, fiberoptic sigmoidosco-
py, enteroclysis, laparotomy and stool analysis, though
capable of detecting inflammation, were included in the
survey principally as distractors. This was done in order
to avoid keying the subjects on white cell scanning and
the tests which are used most prevalently as the principal
modes of IBD diagnosis and evaluation: colonoscopy and
barium enema.
Results
Participant experience
As expected, the experienced group were more likely
than the naive group to have experienced the three focal
tests. Of the 25 experienced participants, 17 had experi-
enced all three focus tests. Three had not had a barium
enema, 2 had not had a white-cell scan, 1 had not had a
colonoscopy, 1 had experienced only a white cell scan,
and 1 had experienced only a colonoscopy.
Of the 38 naive participants, 26 had never experienced
any of the focal tests, 9 had experienced a barium enema
in the past, 1 had experienced a white cell scan, 1 had ex-
perienced a colonoscopy, a 1 had experienced both a bar-
ium enema and a colonoscopy.BMC Medical Research Methodology (2001) 1:5 http://www.biomedcentral.com/1471-2288/1/5
Preference
The Table reports the mean preference ranks assigned to
the three focal tests by each group of participants. Lower
ranks indicate greater preference. Because of the distrac-
tors, ranks could range from 1 (most preferred) to 7 (least
preferred).
Both groups indicated significantly greater preference
for white cell scan than for either colonoscopy or barium
enema (Wilcoxon signed ranks tests, experienced group
WCS vs. colonoscopy, Z = 2.78, naive group WCS vs. bar-
ium enema, Z = 4.05, p < 0.01 for all tests). In the expe-
rienced group, preference order for colonoscopy and
barium enema did not differ significantly (Wilcoxon
signed ranks Z = 0.60), but in the naive group, barium
enema was significantly preferred to colonoscopy (Wil-
coxon signed ranks Z = 4.64).
Dimensions of test experience
The figure presents the mean ranks for the three focal
tests on the dimensions or attributes of physical discom-
fort, inconvenience, embarrassment, and danger for
each group of participants. Lower ranks indicate better
perceptions (less discomfort, inconvenience, embarrass-
ment, or danger).
Physical discomfort and embarrassment ranks essential-
ly duplicated the preference ranks. Both groups consid-
ered white cell scan significantly less uncomfortable and
less embarrassing than either colonoscopy or barium en-
ema (discomfort: Wilcoxon signed ranks tests, experi-
enced group WCS vs. colonoscopy Z = 3.08, naive group
WCS vs. colonoscopy Z = 3.39, p < 0.01; embarrassment:
experienced group WCS vs. barium enema Z = 3.01, na-
ive group WCS vs. barium enema Z = 4.71). The naive
group also expected colonoscopy to be significantly more
uncomfortable than barium enema (Wilcoxon signed
ranks Z = 4.11, p < 0.01) and significantly more embar-
rassing (Wilcoxon signed ranks Z = 2.80, p < 0.01).
Inconvenience ranks were less consistent. In the experi-
enced group, white cell scan was considered significantly
less inconvenient than colonoscopy (Z = -2.39, p < .05),
but not significantly less inconvenient than barium ene-
ma (Z = 1.86). In the naive group, white cell scan was not
considered significantly less inconvenient than either
barium enema (Z = 0.29) or colonoscopy (Z = 1.80). The
naive group did consider colonoscopy to be more incon-
venient than barium enema (Z = 3.33, p < .01).
Danger ranks in each group reflected only the perceived
danger of colonoscopy. In both groups, colonoscopy was
perceived as significantly more dangerous than white
cell scan (experienced group Z = 2.23, naive group Z =
2.49, p < 0.01) and barium enema (experienced group Z
= 3.01, naive group Z = 4.03, p < 0.01). White cell scan
was not considered significantly more or less dangerous
than barium enema by either group.
Excluding naive group members who had experienced
any of the tests and experienced group members who
had not experienced all of the tests did not change the
overall pattern of the results, with two exceptions. After
the exclusion, the naive group ceased to find colonoscopy
significantly more dangerous than white cell scan (Z =
1.60) and ceased to find colonoscopy significantly more
embarrassing than barium enema (Z = 1.59).
Discussion
Clinical usefulness
The clinical usefulness of a diagnostic test is an elusive
paradigm to measure. The test should be reliable (i.e. re-
peatable), but also accurately represent the actual event
or state that must be known (i.e. valid). An assessment of
the radio labeled white cell scan's accuracy has already
satisfied these criteria. There are limits to this accuracy.
Quantitative assessment of disease activity has for the
most part been unsuccessful. But as a dichotomous as-
sessment of inflammatory bowel disease presence, and
anatomic localizer of disease activity, both the initial
published assessment [1] and subsequent clinical experi-
ence have shown the WCS to be an extremely sensitive
diagnostic tool. However usefulness encompasses many
other parameters besides reliability and validity, some
quite qualitative, such as convenience, perceived or
feared pain, compliance or preference, and others more
quantitative such as cost or timely retrieval of results. A
test that performs well in all these areas should allocate
an individual patient to a course that improves clinical
outcome, the quinticential measure of usefulness. In a
chronic illness such as those causing intestinal inflam-
Table 1: Mean Rank Order (lower is preferred)
Test Experienced 
Group
Naive Group
Stool Analysis 1.68 1.23
White cell scan 2.46 2.51
Sigmoidoscopy 3.60 3.41
Colonoscopy 4.20 5.59
Barium Enema 4.28 3.82
Enteroclysis 5.30 5.23
Laparotomy 6.48 6.21
Experienced Group: Patients with inflammatory bowel disease having 
experienced most or all of the above tests. Naive Group; Healthy in-
dividuals previously unfamiliar with most or all of the tests. Scores 
could vary from 1.0 (most preferred) to 7.0 (least preferred).BMC Medical Research Methodology (2001) 1:5 http://www.biomedcentral.com/1471-2288/1/5
mation, where quantifiable absolute survival (as in can-
cer) is not relevant, issues such as accuracy, preference
and cost become paramount in measuring usefulness.
The clear preference for white cell scanning in two very
different populations (Table 1, Figure 1) further estab-
lishes its usefulness in the evaluation of intestinal in-
flammation.
No other surveys could be found of patient preference in
diagnostic evaluation of inflammatory bowel disease, ei-
ther of IBD patients or of healthy individuals. The stud-
ies that have been reported comparing diagnostic tools in
the colorectum have been performed in the context of
colorectal cancer screening [3,4,5,6,7,8], and for the
most part compared barium enema to colonoscopy
[5,6,7,8]. The patient preference ranks often reflected
the source of the study, barium enema preference in
studies reported by radiologists [5] and colonoscopy
preference reported by gastroenterologists [6]. The
amount of sedation administered during the exam varied
widely in these reports and clearly effected impressions.
The sedation administered to the experienced group in
this report might also have been the factor that differen-
tiated impressions of discomfort of colonoscopy between
the experienced and naive groups. There was also, in a
study that presented scripted descriptions of the diag-
nostic tests, what appeared to be prompting that favored
colonoscopy over other choices [3]. In this report we at-
tempted to avoid this by not involving the subject in con-
troversies having to do with test accuracy. It was stated
in the preamble that the subject was to assume that all
tests gave roughly equivalent diagnostic information. In
the context of detection of intestinal inflammation, for
all seven tests listed, this is far closer to being true than
in the context of screening and diagnosis of neoplasia. In
addition several tests were used principally as distractors
(sigmoidoscopy, stool analysis, enteroclysis and laparot-
omy) in order to avoid keying the subject on the compar-
isons of primary interest which were white cell scan
compared to barium enema and colonoscopy. In addi-
tion subjects were not told that one test might inevitably
lead to another. This is of importance regarding WCS as
it was not our practice to follow a positive or negative
scan with a colonoscopy or barium enema unless for oth-
er clinical indications. A WCS combined with sigmoidos-
copy and stool culture (often done at the first visit) was
considered adequate to establish the presence of inflam-
matory bowel disease and initiate treatment.
Figure 1
Mean rank scores for dimensions of test preference. Mean Preference Ranks for the perceived dimensions of discom-
fort, embarrassment, inconvenience and danger in the diagnosis of inflammatory bowel disease comparing colonoscopy, barium
enema and radiolabled white cell scanning in both individuals who have experienced these test (experienced) and those who
have not (naive).BMC Medical Research Methodology (2001) 1:5 http://www.biomedcentral.com/1471-2288/1/5
Conclusion
Two different groups were chosen for the survey to ob-
tain different perspectives of these exams: individuals
who had experienced all of the tests and were burdened
with a chronic illness, and individuals who had experi-
ence or prior impressions of none or few of the tests and
were representative of a healthy population. The former
group is often faced with repeated testing in the course of
their disease and must decide along with their physician
when and how often to undergo evaluation of disease ac-
tivity. The latter naive group may at some time face the
decision how much intervention to undergo in the evalu-
ation of symptoms that may only be functional in etiolo-
gy such as diarrhea or pain. The impressions of these two
groups were remarkably similar. Both showed a clear
preference for WCS over barium enema and colonosco-
py, except for some concern about the time it takes to
perform the radiolabeled white cell scan (Figure 1). If we
are to take these preferences seriously, they could then
be incorporated, along with other outcomes and risks,
into a decision analysis of testing options in inflammato-
ry bowel disease that seeks to maximize the patient's ex-
pected utility [9].
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